Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Pharmaceutical Patent Policy
#2
My client, Biased Argument, is an excellent lawyer. He will fight for any rights he deems necessary for the people, and he furthers government research in NASA and Aerospace research so that additional tests can be conducted in space that simply cannot be done on Earth. He has cut deep into his own pockets due to his extensive belief in the advancement of these sciences. Each trial costs upwards of several hundred million dollars that might prove a negative or, even worse, a false positive which further hampers his own research.

His opponent, Generic Institute, is a private corporation firm that capitalizes on Biased Argument's research and performs none of the research and development while gaining all of the rewards. They also perform some of their own in house testing to make sure their research is just as effective as Biased Argument's without all the aerospace investment. Meanwhile, Biased Argument is really the person that loves you a whole bunch while this evil Generic Institute cares nothing for you.

Should Generic Institute be allowed to perform such mockery? Why do idiot places like this exist?

---------------

Those who market their own drugs get 10 - 15 years of exclusivity for their creation plus whatever lobbying the company can do to increase this benefit for certain drugs. Not to mention that previous presidents (namely Clinton, I believe) provide drug companies with extended exclusivity if they create a specific drug during a time of need such as the Anthrax scare several years back, H1N1, or whooping cough. Also, in many parts of the world the drug gets copied anyway behind the FDA's back and is imported from other countries to skirt approval and bioequivalency claims.

Like all science research, pharmaceutical companies are a high risk entity because so many of them fail. But that's a part of any business. If you look at the survival rate of a business, a significant margin of startups fail within two years. That seems pretty in line with the statistics you've supplied. I don't think pharmaceutical companies are hurting at all - only average with the rest of the business world.
Reply


Messages In This Thread
Pharmaceutical Patent Policy - by Swerve - 2010-10-05, 11:24 PM
Pharmaceutical Patent Policy - by Fiel - 2010-10-05, 11:46 PM
Pharmaceutical Patent Policy - by Swerve - 2010-10-06, 12:29 PM
Pharmaceutical Patent Policy - by Stereo - 2010-10-06, 12:52 PM
Pharmaceutical Patent Policy - by Fiel - 2010-10-06, 01:10 PM
Pharmaceutical Patent Policy - by Swerve - 2010-10-06, 01:33 PM

Forum Jump:


Users browsing this thread: 1 Guest(s)